SCHEMBL21311754

SCHEMBL21311754

O=C1Sc2ccccc2C(I)C2CCCCC12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.35
LMNA P02545 2/20 0.33
TSHR P16473 2/20 0.33
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
PPIA P62937 2/20 0.31
TP53 P04637 1/20 0.31
CYP2D6 P10635 1/20 0.31
CHRM2 P08172 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
CHRM1 P11229 1/20 0.31
DRD1 P21728 1/20 0.31
TBXA2R P21731 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
ADRA1A P35348 1/20 0.31
OPRM1 P35372 1/20 0.31
DRD3 P35462 1/20 0.31
KCNH2 Q12809 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21312488 0.82 PARP1 (0.35) PARP1LMNATSHRMEN1KMT2A
SCHEMBL24119478 0.78 PARP1 (0.33) PARP1LMNATSHRTP53CYP2D6
SCHEMBL21311751 0.75 PPIA (0.40) PARP1MEN1KMT2APPIABCHE
SCHEMBL22879310 0.73 LMNA (0.45) PARP1LMNATSHRMEN1KMT2A
SCHEMBL20829570 0.71
SCHEMBL22879514 0.71 ANPEP (0.45) PARP1MEN1KMT2APPIACHRM1
SCHEMBL22879359 0.71 PARP1 (0.42) PARP1LMNATSHRMEN1KMT2A
SCHEMBL22879372 0.70 CYP2C9 (0.40) PARP1TSHRMEN1KMT2APPIA
SCHEMBL21400548 0.69 HCRTR1 (0.32) SLC6A2SLC6A4
SCHEMBL22879356 0.67 BCHE (0.42) TP53BCHEHTR2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3760620-A1 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USAGE THEREOF Beijing Tide Pharmaceutical Co., Ltd. (CN) 2021-01-06 EP disclosed
WO-2019161781-A1 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USAGE THEREOF 北京泰德制药股份有限公司 2019-08-29 WO disclosed